For priority: 1 = top priority (absolutely necessary), 2 = middle priority (would be useful), 3 = low priority (only if we have time)
Name conventions
pENTR L1-Gene name-L2
pEXPR Promoter:Gene
| Name | Module | Status | Type | Initials | Construction Date | Link | Experiment | Priority |
|---|---|---|---|---|---|---|---|---|
| pEXPR Gal4UAS:eYFP | antibody | in someone else's freezer | expression | |||||
| pEXPR Gal4UAS:mKate | antibody | in someone else's freezer | expression | |||||
| pEXPR Tre-TEVp | antibody | in someone else's freezer | expression | |||||
| Hef1a-rtTa | antibody | in someone else's freezer | expression | |||||
| CD79A WT | antibody | miniprepped, awaiting sequence verification | ||||||
| CD79B WT | antibody | miniprepped, awaiting sequence verification | ||||||
| CD79A-TCS-Gal4VP16 | antibody | planned | ||||||
| CD79B-TCS-Gal4VP16 | antibody | planned | ||||||
| Lyn WT | antibody | growing in LB, ready at 7am | ||||||
| Lyn-eYFP | antibody | planned | ||||||
| Lyn point mutated (always phosphorylate) | antibody | researching | ||||||
Syk WT | antibody | growing in LB, ready at 7am | ||||||
| Syk-eYFP (mutant non phosphorylate) | antibody | planned | ||||||
| Syk-TEVp | antibody | planned | ||||||
| GMab k | antibody | on order | ||||||
| GMab H | antibody | on order | ||||||
| GMabH-TCS-Gal4VP16 | antibody | planned | ||||||
| hsa-miR-181c | miRNA | planned | ||||||
| hsa-miR-9 | miRNA | planned | ||||||
| hsa-miR-30d-5p | miRNA | planned | ||||||
| hsa-miR-144-5p | miRNA | planned | ||||||
| hsa-let-7f-5p | miRNA | planned | ||||||
| has-miR-125b | miRNA | planned | ||||||
| has-miR-146a | miRNA | planned | ||||||
| pEXPR TRE-t:BACE2-eYFP | treatment | planned | ||||||
| treatment | in the lab already | ||||||
| treatment | planned | ||||||
| treatment | ordered | ||||||
| treatment | in the lab already | ||||||
| treatment | in the lab already | ||||||
| pEXPR Hef1a:BACE1-eYFP | treatment | planned | ||||||
| treatment | in the lab already | ||||||
| treatment | planned | ||||||
| treatment | to be ordered | ||||||
| treatment | in the lab already | ||||||
| treatment | in the lab already | ||||||
| pEXPR U6:mKate-miRNA(intronic) | treatment | planned | ||||||
| pEXPR U6/TRE-t(hybrid promoter):mKate-miRNA(intronic) | treatment | planned |